KIM; Misoon

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Misoon.The latest application filed is for "imidazopyridinyl compounds and use thereof for treatment of proliferative disorders".

Company Profile

6.3.9

KIM; Misoon - Gyeonggi-do KR
Kim; Misoon - Yongin KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Proliferative Disorders App 20220242861 - LEE; Jinhwa ; et al.	2022-08-04
Indazoles As Hematopoietic Progenitor Kinase 1 (hpk1) Inhibitors And Methods Using Same App 20220098193 - LEE; Jinhwa ; et al.	2022-03-31
Indazoles As Hematopoietic Progenitor Kinase 1 (hpk1) Inhibitors And Methods Using Same App 20220098219 - LEE; Jinhwa ; et al.	2022-03-31
2-amino-3-carbonyl Imidazopyridine And Pyrazolopyridine Compounds App 20220087985 - LEE; Jinhwa ; et al.	2022-03-24
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Neurodegenerative Disorders App 20210347774 - LEE; Jinhwa ; et al.	2021-11-11
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders Grant 11,098,044 - Lee , et al. August 24, 2	2021-08-24
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders Grant 10,968,188 - Lee , et al. April 6, 2	2021-04-06
Benzothiazol Compounds And Methods Using The Same For Treating Neurodegenerative Disorders App 20200270222 - LEE; Jinhwa ; et al.	2020-08-27
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Neurodegenerative Disorders App 20200270246 - LEE; Jinhwa ; et al.	2020-08-27
Benzothiazol Compounds And Methods Using The Same For Treating Neurodegenerative Disorders App 20190100500 - LEE; Jinhwa ; et al.	2019-04-04
Fused ring heteroaryl compounds and their use as Trk inhibitors Grant 9,701,681 - Kim , et al. July 11, 2	2017-07-11
Fused Ring Heteroaryl Compounds And Their Use As Trk Inhibitors App 20160168156 - Kim; Moonsoo ; et al.	2016-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.